Journal of Ovarian Research (Dec 2019)

Ovarian cancer stem cells and targeted therapy

  • Vahideh Keyvani,
  • Moein Farshchian,
  • Seyed-Alireza Esmaeili,
  • Hadi Yari,
  • Meysam Moghbeli,
  • Seyed-Reza Kazemi Nezhad,
  • Mohammad Reza Abbaszadegan

DOI
https://doi.org/10.1186/s13048-019-0588-z
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background Ovarian cancer has the highest ratio of mortality among gynecologic malignancies. Chemotherapy is one of the most common treatment options for ovarian cancer. However, tumor relapse in patients with advanced tumor stage is still a therapeutic challenge for its clinical management. Main body Therefore, it is required to clarify the molecular biology and mechanisms which are involved in chemo resistance to improve the survival rate of ovarian cancer patients. Cancer stem cells (CSCs) are a sub population of tumor cells which are related to drug resistance and tumor relapse. Conclusion In the present review, we summarized the recent findings about the role of CSCs in tumor relapse and drug resistance among ovarian cancer patients. Moreover, we focused on the targeted and combinational therapeutic methods against the ovarian CSCs.

Keywords